Physician profile
Jayde Barnes
NPI 1023618659
$2,593.20
in general payments reported to CMS, 2019-2025
15 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $792 · 2023: $577 · 2024: $920 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653 · Education: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.36 |
| Education | $147.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $772.65 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $503.38 | 2022-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $250.36 | 2022-2024 | Austedo Xr, Uzedy, Austedo |
| Otsuka America Pharmaceutical, INC. | $190.90 | 2022-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Axsome Therapeutics, INC. | $173.92 | 2023-2025 | Auvelity |
| Indivior INC. | $146.43 | 2022-2025 | Sublocade, Perseris |
| Janssen Pharmaceuticals, INC | $141.06 | 2022-2023 | Spravato |
| Vanda Pharmaceuticals INC. | $86.51 | 2023-2025 | Fanapt, Hetlioz |
| Ironshore Pharmaceuticals INC. | $81.62 | 2022-2024 | Jornay Pm |
| Lundbeck LLC | $61.12 | 2024 | Rexulti |
| Alkermes, INC. | $55.95 | 2022-2025 | Aristada, Aristada Initio, Lybalvi |
| Neurocrine Biosciences, INC. | $50.20 | 2023-2024 | Ingrezza |
| Corium, LLC | $39.01 | 2022-2023 | Azstarys |
| Hologic Sales and Service, LLC | $24.32 | 2025 | Thinprep 2000 Processor, Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.77 | 2024 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayde Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.